-Trastuzumab-functionalized nanoparticles showed significant cell uptake and cytotoxic effect against HER-2 positive breast cancer cells.-Potential candidate for active targeting HER-2 positive breast cancer treatment. Here, ERBB2 is linked to breast cancer.